Double treatment for teen obesity: surgery plus drug shows promise
NCT ID NCT06934655
Summary
This study is testing if restarting a weekly weight-loss injection (semaglutide) just two weeks after a common stomach-reduction surgery helps teens with severe obesity. It will compare 150 teens who get the drug after surgery to those who get surgery alone over two years. The goal is to see if the combined approach is safe and leads to better weight loss, improved heart and metabolic health, and healthier eating habits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Conditions
Explore the condition pages connected to this study.